{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:29:21Z","timestamp":1784762961183,"version":"3.55.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heares.2022.108523","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T17:58:49Z","timestamp":1652723929000},"page":"108523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Altering gene expression using antisense oligonucleotide therapy for hearing loss"],"prefix":"10.1016","volume":"426","author":[{"given":"Katelyn N.","family":"Robillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"de Vrieze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-4370","authenticated-orcid":false,"given":"Jennifer J.","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2022.108523_bib0001","article-title":"Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4","volume":"19","author":"Abad-Morales","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"24","key":"10.1016\/j.heares.2022.108523_bib0002","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1093\/hmg\/ddi416","article-title":"Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells","volume":"14","author":"Adato","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0003","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00439-002-0732-4","article-title":"Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC","volume":"110","author":"Ahmed","year":"2002","journal-title":"Hum Genet"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0004","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1073\/pnas.1817537116","article-title":"Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model","volume":"116","author":"Akil","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"97","key":"10.1016\/j.heares.2022.108523_bib0005","doi-asserted-by":"crossref","DOI":"10.3791\/52187-v","article-title":"Surgical method for virally mediated gene delivery to the mouse inner ear through the round window membrane","author":"Akil","year":"2015","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuron.2012.05.019","article-title":"Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy","volume":"75","author":"Akil","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s13346-020-00782-9","article-title":"Drug delivery device for the inner ear: ultra-sharp fully metallic microneedles","volume":"11","author":"Aksit","year":"2021","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0008","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.2069","article-title":"A small molecule mitigates hearing loss in a mouse model of Usher syndrome III","volume":"12","author":"Alagramam","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.heares.2022.108523_bib0009","series-title":"CHAPTER 20 Preclinical and Clinical Drug-metabolism, Pharmacokinetics and Safety of Therapeutic Oligonucleotides, Advances in Nucleic Acid Therapeutics","first-page":"474","author":"Andersson","year":"2019"},{"issue":"D1","key":"10.1016\/j.heares.2022.108523_bib0010","first-page":"D1006","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR\/MMV Guide to MALARIA PHARMACOLOGY","volume":"48","author":"Armstrong","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"295","key":"10.1016\/j.heares.2022.108523_bib0011","doi-asserted-by":"crossref","first-page":"295ra108","DOI":"10.1126\/scitranslmed.aab1996","article-title":"Tmc gene therapy restores auditory function in deaf mice","volume":"7","author":"Askew","year":"2015","journal-title":"Sci Transl Med"},{"issue":"18","key":"10.1016\/j.heares.2022.108523_bib0012","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2032-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells","volume":"272","author":"Baker","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0013","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1179\/146701011X13001035752570","article-title":"Executive function in everyday life: implications for young cochlear implant users","volume":"12","author":"Beer","year":"2011","journal-title":"Cochlear Implants Int"},{"issue":"43","key":"10.1016\/j.heares.2022.108523_bib0014","doi-asserted-by":"crossref","first-page":"25702","DOI":"10.1074\/jbc.270.43.25702","article-title":"Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance","volume":"270","author":"Beigelman","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.heares.2022.108523_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"11-12","key":"10.1016\/j.heares.2022.108523_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.06.006","article-title":"More than a messenger: Alternative splicing as a therapeutic target","volume":"1862","author":"Black","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.heares.2022.108523_bib0017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.02.008","article-title":"Delivery of therapeutic oligonucleotides with cell penetrating peptides","volume":"87","author":"Boisguerin","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/WCO.0b013e32834ef8b2","article-title":"Usher syndrome (sensorineural deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches","volume":"25","author":"Bonnet","year":"2012","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0019","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/humu.23384","article-title":"Exonic mutations and exon skipping: Lessons learned from DFNA5","volume":"39","author":"Booth","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.heares.2022.108523_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-5521(94)90014-0","article-title":"A DNA enzyme that cleaves RNA","volume":"1","author":"Breaker","year":"1994","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.heares.2022.108523_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-3271-9_4","article-title":"Regulated Gene Therapy","volume":"1382","author":"Breger","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"139","key":"10.1016\/j.heares.2022.108523_bib0022","doi-asserted-by":"crossref","first-page":"139ra182","DOI":"10.1126\/scitranslmed.3003960","article-title":"DNAzyme targeting c-jun suppresses skin cancer growth","volume":"4","author":"Cai","year":"2012","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0023","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/bc0200024","article-title":"Artificial ribonucleases: efficient and specific in vitro cleavage of human c-raf-1 RNA","volume":"13","author":"Canaple","year":"2002","journal-title":"Bioconjug Chem"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0024","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","article-title":"Ribonuclease H: the enzymes in eukaryotes","volume":"276","author":"Cerritelli","year":"2009","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0025","article-title":"The Structure-To-Function Relationships of Gammaherpesvirus-Encoded Long Non-Coding RNAs and Their Contributions to Viral Pathogenesis","volume":"4","author":"Chavez-Calvillo","year":"2018","journal-title":"Noncoding RNA"},{"issue":"17","key":"10.1016\/j.heares.2022.108523_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17176336","article-title":"Dextromethorphan Attenuates Sensorineural Hearing Loss in an Animal Model and Population-Based Cohort Study","volume":"17","author":"Chen","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.heares.2022.108523_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-6123-4_1","article-title":"Hair Cell Regeneration","volume":"1130","author":"Chen","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0028","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0029","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1097\/MAO.0000000000001936","article-title":"Cognitive Performance of Severely Hearing-impaired Older Adults Before and After Cochlear Implantation: Preliminary Results of a Prospective, Longitudinal Cohort Study Using the RBANS-H","volume":"39","author":"Claes","year":"2018","journal-title":"Otol Neurotol"},{"issue":"10278","key":"10.1016\/j.heares.2022.108523_bib0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(21)00516-X","article-title":"Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heares.2022.108523_bib0031","author":"Collins","year":"2013","journal-title":"NIH Director's Blog: Tackling the Bottlenecks in the Drug Development Pipeline"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0032","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","article-title":"Phosphorothioate modified oligonucleotide-protein interactions","volume":"48","author":"Crooke","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0033","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0038-1666820","article-title":"Cochlear Implants and Children with Vestibular Impairments","volume":"39","author":"Cushing","year":"2018","journal-title":"Semin Hear"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0034","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10162-017-0628-6","article-title":"Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery","volume":"18","author":"Dai","year":"2017","journal-title":"J Assoc Res Otolaryngol"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083910","article-title":"Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy","volume":"22","author":"de Joya","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.heares.2022.108523_bib0036","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtn.2021.02.033","article-title":"AON-based degradation of c.151C>T mutant COCH transcripts associated with dominantly inherited hearing impairment DFNA9","volume":"24","author":"de Vrieze","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10.1016\/j.heares.2022.108523_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072309","article-title":"Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges","volume":"9","author":"Delmaghani","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0038","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1523\/JNEUROSCI.22-05-01718.2002","article-title":"Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness","volume":"22","author":"Delprat","year":"2002","journal-title":"J Neurosci"},{"issue":"20","key":"10.1016\/j.heares.2022.108523_bib0039","first-page":"9519","article-title":"Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse","volume":"44","author":"Depreux","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.12968\/hmed.2019.80.9.525","article-title":"What is noise-induced hearing loss?","volume":"80","author":"Ding","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.heares.2022.108523_bib0041","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2017.10.012","article-title":"Antisense oligonucleotide therapy rescues disruptions in organization of exploratory movements associated with Usher syndrome type 1C in mice","volume":"338","author":"Donaldson","year":"2018","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0042","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.otc.2015.06.007","article-title":"Management of Conductive Hearing Loss in Children","volume":"48","author":"Dougherty","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0043","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ymthe.2018.03.004","article-title":"Regeneration of Cochlear Hair Cells and Hearing Recovery through Hes1 Modulation with siRNA Nanoparticles in Adult Guinea Pigs","volume":"26","author":"Du","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.heares.2022.108523_bib0044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.heares.2013.06.011","article-title":"Regeneration of mammalian cochlear and vestibular hair cells through Hes1\/Hes5 modulation with siRNA","volume":"304","author":"Du","year":"2013","journal-title":"Hear Res"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0045","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","article-title":"Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations","volume":"29","author":"Dulla","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.heares.2022.108523_bib0046","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4939-2253-6_11","article-title":"RNA antisense purification (RAP) for mapping RNA interactions with chromatin","volume":"1262","author":"Engreitz","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0047","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","article-title":"RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites","volume":"159","author":"Engreitz","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0048","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/geno.1998.5345","article-title":"Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41","volume":"50","author":"Eudy","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.heares.2022.108523_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.108092","article-title":"Breaking the sound barrier: Towards next-generation AAV vectors for gene therapy of hearing disorders","volume":"413","author":"Fakhiri","year":"2022","journal-title":"Hear Res"},{"issue":"9820","key":"10.1016\/j.heares.2022.108523_bib0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(11)61143-4","article-title":"Mental health of deaf people","volume":"379","author":"Fellinger","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.heares.2022.108523_bib0051","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2019.11.051","article-title":"Noise-induced Cochlear Synaptopathy with and Without Sensory Cell Loss","volume":"427","author":"Fernandez","year":"2020","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0052","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MOO.0000000000000648","article-title":"Microtechnologies for inner ear drug delivery","volume":"28","author":"Forouzandeh","year":"2020","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00003446-198409000-00004","article-title":"Adaptation of the acoustic reflex","volume":"5","author":"Fowler","year":"1984","journal-title":"Ear Hear"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0054","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/13816810.2021.1891552","article-title":"Multimodal imaging and genetic findings in a case of ARSG-related atypical Usher syndrome","volume":"42","author":"Fowler","year":"2021","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0192623314551840","article-title":"Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective","volume":"43","author":"Frazier","year":"2015","journal-title":"Toxicol Pathol"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0056","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3766\/jaaa.23.10.7","article-title":"Hearing loss associated with xylene exposure in a laboratory worker","volume":"23","author":"Fuente","year":"2012","journal-title":"J Am Acad Audiol"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0057","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.gt.3301955","article-title":"Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions","volume":"10","author":"Furling","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.heares.2022.108523_bib0058","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fncel.2019.00532","article-title":"Forgotten Fibrocytes: A Neglected, Supporting Cell Type of the Cochlea With the Potential to be an Alternative Therapeutic Target in Hearing Loss","volume":"13","author":"Furness","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0059","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1152\/jn.00306.2014","article-title":"Vibration of the organ of Corti within the cochlear apex in mice","volume":"112","author":"Gao","year":"2014","journal-title":"J Neurophysiol"},{"issue":"7687","key":"10.1016\/j.heares.2022.108523_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","article-title":"Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.heares.2022.108523_bib0061","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0062","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2105\/AJPH.2016.303299","article-title":"Prevalence of Hearing Loss by Severity in the United States","volume":"106","author":"Goman","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.heares.2022.108523_bib0063","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-61779-767-5_17","article-title":"Engineering U7snRNA gene to reframe transcripts","volume":"867","author":"Goyenvalle","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.heares.2022.108523_bib0064","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/mt.2009.113","article-title":"Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy","volume":"17","author":"Goyenvalle","year":"2009","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41576-019-0145-z","article-title":"Alternative cleavage and polyadenylation in health and disease","volume":"20","author":"Gruber","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.heares.2022.108523_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.760422","article-title":"Autophagy Regulates the Survival of Hair Cells and Spiral Ganglion Neurons in Cases of Noise, Ototoxic Drug, and Age-Induced Sensorineural Hearing Loss","volume":"15","author":"Guo","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.heares.2022.108523_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2018.11.003","article-title":"Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate","volume":"13","author":"Gyorgy","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.heares.2022.108523_bib0068","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41591-019-0500-9","article-title":"Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss","volume":"25","author":"Gyorgy","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0069","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2105\/AJPH.2018.304498","article-title":"Influence of Hearing Loss on Child Behavioral and Home Experiences","volume":"108","author":"Hall","year":"2018","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOO.0b013e32830ce796","article-title":"Issues, indications, and controversies regarding intratympanic steroid perfusion","volume":"16","author":"Hamid","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0071","doi-asserted-by":"crossref","first-page":"e13243","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of oligonucleotide-based therapeutics: challenges and opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0072","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00439-018-1936-6","article-title":"Knockout of ush2a gene in zebrafish causes hearing impairment and late onset rod-cone dystrophy","volume":"137","author":"Han","year":"2018","journal-title":"Hum Genet"},{"key":"10.1016\/j.heares.2022.108523_bib0073","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.heares.2016.06.008","article-title":"A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa","volume":"339","author":"Hartel","year":"2016","journal-title":"Hear Res"},{"key":"10.1016\/j.heares.2022.108523_bib0074","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.ai.2016.11.001","article-title":"Nucleic Acid Immunity","volume":"133","author":"Hartmann","year":"2017","journal-title":"Adv Immunol"},{"key":"10.1016\/j.heares.2022.108523_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.107931","article-title":"Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction","volume":"394","author":"Hastings","year":"2020","journal-title":"Hear Res"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0076","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s13311-019-00729-0","article-title":"Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction","volume":"16","author":"Hastings","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"14","key":"10.1016\/j.heares.2022.108523_bib0077","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0078","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.heares.2022.108523_bib0079","year":"2021","journal-title":"Noise and hearing loss prevention"},{"key":"10.1016\/j.heares.2022.108523_bib0080","year":"2022","journal-title":"Hearing Loss in Numbers"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0081","first-page":"1","article-title":"Year 2019 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs","volume":"4","year":"2019","journal-title":"The Journal of Early Hearing Detection and Intervention"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0082","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3565(24)36667-4","article-title":"Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action","volume":"281","author":"Henry","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9081018","article-title":"Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease","volume":"9","author":"Hildreth","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.heares.2022.108523_bib0084","author":"Hill","year":"2021","journal-title":"Somitogenesis"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1469-7610.1994.tb02302.x","article-title":"Psychiatric disorder in deaf and hearing impaired children and young people: a prevalence study","volume":"35","author":"Hindley","year":"1994","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0086","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10162-014-0476-6","article-title":"Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph","volume":"15","author":"Hirose","year":"2014","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.heares.2022.108523_bib0087","first-page":"Doc08","article-title":"Hearing aids: indications, technology, adaptation, and quality control","volume":"16","author":"Hoppe","year":"2017","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0088","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"Hu","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"15","key":"10.1016\/j.heares.2022.108523_bib0089","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.heares.2022.108523_bib0090","article-title":"Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges","volume":"834079","author":"Huang","year":"2015","journal-title":"Biomed Res Int 2015"},{"key":"10.1016\/j.heares.2022.108523_bib0091","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-9065-8_13","article-title":"Surgical Methods for Inner Ear Gene Delivery in Neonatal Mouse","volume":"1937","author":"Isgrig","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0092","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ymthe.2017.01.007","article-title":"Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome","volume":"25","author":"Isgrig","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.heares.2022.108523_bib0093","year":"2021","journal-title":"IUPHAR\/BPS Guide to Pharmacology"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0094","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nchembio860","article-title":"Activating gene expression in mammalian cells with promoter-targeted duplex RNAs","volume":"3","author":"Janowski","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41431-017-0066-2","article-title":"Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment","volume":"26","author":"JanssensdeVarebeke","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.heares.2022.108523_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.699978","article-title":"Noise-Induced Hearing Loss in Gerbil: Round Window Assays of Synapse Loss","volume":"15","author":"Jeffers","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"10.1016\/j.heares.2022.108523_bib0097","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0098","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1523-1747.2002.19642.x","article-title":"Ribozyme therapeutics","volume":"7","author":"Kashani-Sabet","year":"2002","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0099","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0194-59989670008-6","article-title":"Repair of chronic tympanic membrane perforations with fibroblast growth factor","volume":"115","author":"Kato","year":"1996","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.heares.2022.108523_bib0100","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/cddis.2011.63","article-title":"Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation","volume":"2","author":"Kaur","year":"2011","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0101","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1007\/s12032-010-9681-2","article-title":"EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model","volume":"28","author":"Ke","year":"2011","journal-title":"Med Oncol"},{"issue":"R1","key":"10.1016\/j.heares.2022.108523_bib0102","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0103","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archoto.2009.202","article-title":"Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss","volume":"136","author":"Kenna","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0104","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41598-017-01577-8","article-title":"A deep intronic CLRN1 (USH3A) founder mutation generates an aberrant exon and underlies severe Usher syndrome on the Arabian Peninsula","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.heares.2022.108523_bib0106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/ars.2015.6442","article-title":"Methionine Sulfoxide Reductase B3-Targeted In Utero Gene Therapy Rescues Hearing Function in a Mouse Model of Congenital Sensorineural Hearing Loss","volume":"24","author":"Kim","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.heares.2022.108523_bib0107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.heares.2019.01.003","article-title":"Hereditary hearing loss; about the known and the unknown","volume":"376","author":"Kremer","year":"2019","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0108","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(99)00147-5","article-title":"Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides","volume":"1489","author":"Krieg","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0109","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Krutzfeldt","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jimd.12251","article-title":"Opportunities and challenges for antisense oligonucleotide therapies","volume":"44","author":"Kuijper","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"Pt B","key":"10.1016\/j.heares.2022.108523_bib0111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.heares.2015.02.009","article-title":"Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss","volume":"330","author":"Kujawa","year":"2015","journal-title":"Hear Res"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tibs.2018.11.001","article-title":"Advanced Selection Methodologies for DNAzymes in Sensing and Healthcare Applications","volume":"44","author":"Kumar","year":"2019","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0113","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.molcel.2019.12.029","article-title":"Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination","volume":"77","author":"Lai","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.heares.2022.108523_bib0114","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0115","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1097\/AUD.0000000000000250","article-title":"Qualities of Single Electrode Stimulation as a Function of Rate and Place of Stimulation with a Cochlear Implant","volume":"37","author":"Landsberger","year":"2016","journal-title":"Ear Hear"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0116","first-page":"1172","article-title":"Modified U1 snRNA and antisense oligonucleotides rescue splice mutations in SLC26A4 that cause hereditary hearing loss","volume":"40","author":"Lee","year":"2019","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00439-004-1217-4","article-title":"The USH1C 216G\u2013>A splice-site mutation results in a 35-base-pair deletion","volume":"116","author":"Lentz","year":"2005","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0118","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nm.3106","article-title":"Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness","volume":"19","author":"Lentz","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.heares.2022.108523_bib0119","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.ymthe.2020.08.002","article-title":"Direct Delivery of Antisense Oligonucleotides to the Middle and Inner Ear Improves Hearing and Balance in Usher Mice","volume":"28","author":"Lentz","year":"2020","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0121","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","article-title":"RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus","volume":"25","author":"Liang","year":"2017","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0122","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030762","article-title":"RNA Trans-Splicing Modulation via Antisense Molecule Interference","volume":"19","author":"Liemberger","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.heares.2022.108523_bib0123","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.2020.17647","article-title":"Hearing Loss in Children: A Review","volume":"324","author":"Lieu","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0124","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.106.025015","article-title":"Human RNase H1 discriminates between subtle variations in the structure of the heteroduplex substrate","volume":"71","author":"Lima","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.heares.2022.108523_bib0125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0126","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/humu.22926","article-title":"Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations","volume":"37","author":"Liquori","year":"2016","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0127","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0128","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.cell.2016.04.028","article-title":"RNA Duplex Map in Living Cells Reveals Higher-Order Transcriptome Structure","volume":"165","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.heares.2022.108523_bib0129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pharmthera.2019.05.003","article-title":"New molecular therapies for the treatment of hearing loss","volume":"200","author":"Ma","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.heares.2022.108523_bib0130","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/hmg\/ddi172","article-title":"In vitro and in vivo suppression of GJB2 expression by RNA interference","volume":"14","author":"Maeda","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0194599817715235","article-title":"Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation","volume":"157","author":"Magliulo","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.heares.2022.108523_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.107927","article-title":"Viral vectors for gene delivery to the inner ear","volume":"394","author":"Maguire","year":"2020","journal-title":"Hear Res"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0133","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.1002\/wrna.1518","article-title":"The evolution of RNA structural probing methods: From gels to next-generation sequencing","volume":"10","author":"Mailler","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0134","first-page":"611","article-title":"Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J Biol Med"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/hmg\/ddn382","article-title":"Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation","volume":"18","author":"Meyer","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.heares.2022.108523_bib0136","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/MAO.0b013e31818658ea","article-title":"Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures","volume":"29","author":"Mikulec","year":"2008","journal-title":"Otol Neurotol"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0137","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/nar\/gkt066","article-title":"The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides","volume":"41","author":"Ming","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0138","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/nar\/gkh626","article-title":"Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1","volume":"32","author":"Mitchell","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0139","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/mt.2013.62","article-title":"Mouse otocyst transuterine gene transfer restores hearing in mice with connexin 30 deletion-associated hearing loss","volume":"21","author":"Miwa","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.heares.2022.108523_bib0140","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1097\/AUD.0000000000000210","article-title":"An Introduction to the Outcomes of Children with Hearing Loss Study","volume":"36","author":"Moeller","year":"2015","journal-title":"Ear Hear"},{"issue":"28","key":"10.1016\/j.heares.2022.108523_bib0141","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1016\/S0021-9258(19)88650-7","article-title":"Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides","volume":"267","author":"Monia","year":"1992","journal-title":"J Biol Chem"},{"issue":"5688","key":"10.1016\/j.heares.2022.108523_bib0142","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1101372","article-title":"Small interfering RNA-induced transcriptional gene silencing in human cells","volume":"305","author":"Morris","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0143","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cbpa.2004.02.006","article-title":"Synthetic metallonucleases for RNA cleavage","volume":"8","author":"Morrow","year":"2004","journal-title":"Curr Opin Chem Biol"},{"issue":"49","key":"10.1016\/j.heares.2022.108523_bib0144","doi-asserted-by":"crossref","first-page":"13056","DOI":"10.1523\/JNEUROSCI.1307-08.2008","article-title":"Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat","volume":"28","author":"Mukherjea","year":"2008","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.heares.2022.108523_bib0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.heares.2022.108523_bib0146","first-page":"750","article-title":"Antisense Phosphorodiamidate Morpholino Oligomers as","volume":"9","author":"Nan","year":"2018","journal-title":"Novel Antiviral Compounds. Front Microbiol"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0147","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/79951","article-title":"Effective targeted gene 'knockdown' in zebrafish","volume":"26","author":"Nasevicius","year":"2000","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0148","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/13816810.2020.1747090","article-title":"Atypical and ultra-rare Usher syndrome: a review","volume":"41","author":"Nolen","year":"2020","journal-title":"Ophthalmic Genet"},{"issue":"482","key":"10.1016\/j.heares.2022.108523_bib0149","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.heares.2022.108523_bib0150","year":"2021","journal-title":"Deafness and hearing loss"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0151","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00439-002-0736-0","article-title":"Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness","volume":"111","author":"Ouyang","year":"2002","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0152","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nbt.3801","article-title":"Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c","volume":"35","author":"Pan","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.heares.2022.108523_bib0153","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.omtn.2020.07.036","article-title":"Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation","volume":"21","author":"Panagiotopoulos","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.heares.2022.108523_bib0154","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","author":"Paunovska","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.heares.2022.108523_bib0155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.580639","article-title":"On the Role of Fibrocytes and the Extracellular Matrix in the Physiology and Pathophysiology of the Spiral Ligament","volume":"11","author":"Peeleman","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.heares.2022.108523_bib0156","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-030-27378-1_15","article-title":"In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases","volume":"1185","author":"Pendse","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6099","key":"10.1016\/j.heares.2022.108523_bib0157","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.337.6099.1159","article-title":"Genomics. ENCODE project writes eulogy for junk DNA","volume":"337","author":"Pennisi","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0158","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAO.0b013e318161aaae","article-title":"Dexamethasone concentration gradients along scala tympani after application to the round window membrane","volume":"29","author":"Plontke","year":"2008","journal-title":"Otol Neurotol"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10162-017-0640-x","article-title":"Rescue of Outer Hair Cells with Antisense Oligonucleotides in Usher Mice Is Dependent on Age of Treatment","volume":"19","author":"Ponnath","year":"2018","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.heares.2022.108523_bib0160","year":"2022","journal-title":"Ultevursen for USH2A mediated retinitis pigmentosa and Usher syndrome"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0161","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010035","article-title":"Interplay between Nutrition and Hearing Loss: State of Art","volume":"11","author":"Puga","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0162","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.immuni.2013.01.015","article-title":"Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity","volume":"38","author":"Py","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0163","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gt.2013.49","article-title":"Efficient siRNA transfection to the inner ear through the intact round window by a novel proteidic delivery technology in the chinchilla","volume":"21","author":"Qi","year":"2014","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/oli.1.2000.10.11","article-title":"In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alpha","volume":"10","author":"Qin","year":"2000","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","article-title":"Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs","volume":"37","author":"Qu","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0166","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1086\/302926","article-title":"Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss","volume":"66","author":"Rivolta","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.heares.2022.108523_bib0167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082692","article-title":"New Insights on the Effect of TNF Alpha Blockade by Gene Silencing in Noise-Induced Hearing Loss","volume":"21","author":"Rodrigues","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(00)00085-5","article-title":"Ribozyme therapy for HIV infection","volume":"44","author":"Rossi","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"issue":"14","key":"10.1016\/j.heares.2022.108523_bib0169","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00018-012-1016-3","article-title":"siRNA-mediated knock-down of NOX3: therapy for hearing loss?","volume":"69","author":"Rybak","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.heares.2022.108523_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fncel.2019.00161","article-title":"Drug Diffusion Along an Intact Mammalian Cochlea","volume":"13","author":"Sadreev","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.heares.2022.108523_bib0171","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2017.12.010","article-title":"Communication pathways to and from the inner ear and their contributions to drug delivery","volume":"362","author":"Salt","year":"2018","journal-title":"Hear Res"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0172","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","article-title":"Principles of local drug delivery to the inner ear","volume":"14","author":"Salt","year":"2009","journal-title":"Audiol Neurootol"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0173","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa1807838","article-title":"Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria","volume":"380","author":"Sardh","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0174","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12070-017-1213-3","article-title":"Intratympanic Injection of Steroid for Treatment of Tinnitus","volume":"71","author":"Sayoo","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0175","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/nar\/gkz1132","article-title":"Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides","volume":"48","author":"Scharner","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0176","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MAO.0000000000002194","article-title":"Hearing Protection, Restoration, and Regeneration: An Overview of Emerging Therapeutics for Inner Ear and Central Hearing Disorders","volume":"40","author":"Schilder","year":"2019","journal-title":"Otol Neurotol"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0177","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000006","article-title":"Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression","volume":"4","author":"Serre","year":"2008","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0179","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI125228","article-title":"Selective tissue targeting of synthetic nucleic acid drugs","volume":"129","author":"Seth","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.heares.2022.108523_bib0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fgene.2019.00868","article-title":"Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders","volume":"10","author":"Shahryari","year":"2019","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0181","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0022215120001012","article-title":"Hearing loss and employment: a systematic review of the association between hearing loss and employment among adults","volume":"134","author":"Shan","year":"2020","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.heares.2022.108523_bib0182","unstructured":"Shearer, A.E., Hildebrand, M.S., Smith, R.J.H., 1993. Hereditary Hearing Loss and Deafness Overview, in: Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Mirzaa, G., Amemiya, A. (Eds.), GeneReviews((R)). Seattle (WA)."},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0183","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajhg.2016.03.028","article-title":"RNA Interference Prevents Autosomal-Dominant Hearing Loss","volume":"98","author":"Shibata","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0184","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/zeb.2018.1613","article-title":"Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A","volume":"15","author":"Slijkerman","year":"2018","journal-title":"Zebrafish"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0185","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1038\/mtna.2016.89","article-title":"Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation","volume":"5","author":"Slijkerman","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0186","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2478\/v10001-007-0032-2","article-title":"Exposure to organic solvent mixture and hearing loss: literature overview","volume":"20","author":"Sliwinska-Kowalska","year":"2007","journal-title":"Int J Occup Med Environ Health"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0187","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00439-016-1648-8","article-title":"Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss","volume":"135","author":"Sloan-Heggen","year":"2016","journal-title":"Hum Genet"},{"issue":"461","key":"10.1016\/j.heares.2022.108523_bib0188","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3959","article-title":"Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease","volume":"10","author":"Southwell","year":"2018","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0189","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-Approved Oligonucleotide Therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0191","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.bmc.2019.03.057","article-title":"Unveiling the druggable RNA targets and small molecule therapeutics","volume":"27","author":"Sztuba-Solinska","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0192","first-page":"H2392","article-title":"Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension","volume":"277","author":"Tang","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0193","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.20172246","article-title":"CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss","volume":"215","author":"Teitz","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.heares.2022.108523_bib0194","doi-asserted-by":"crossref","DOI":"10.1089\/nat.2021.0021","article-title":"Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System","author":"Umek","year":"2021","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/humu.21634","article-title":"Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy","volume":"33","author":"Vache","year":"2012","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0196","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21695717.2020.1807261","article-title":"Inner Ear Gene Delivery: Vectors and Routes","volume":"18","author":"Valentini","year":"2020","journal-title":"Hearing Balance Commun"},{"key":"10.1016\/j.heares.2022.108523_bib0197","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fneur.2020.00290","article-title":"Making the Case for Research on Disease-Modifying Treatments to Tackle Post-lingual Progressive Sensorineural Hearing Loss","volume":"11","author":"Van Rompaey","year":"2020","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.heares.2022.108523_bib0198","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/hmg\/ddi490","article-title":"The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1","volume":"15","author":"van Wijk","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.heares.2022.108523_bib0199","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/17460441.2020.1806232","article-title":"Drug development for noise-induced hearing loss","volume":"15","author":"Varela-Nieto","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.heares.2022.108523_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.108162","article-title":"On the pathophysiology of DFNA9: Effect of pathogenic variants in the COCH gene on inner ear functioning in human and transgenic mice","volume":"401","author":"Verdoodt","year":"2021","journal-title":"Hear Res"},{"issue":"10","key":"10.1016\/j.heares.2022.108523_bib0201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108625","article-title":"Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms","volume":"9","author":"Vickers","year":"2014","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.heares.2022.108523_bib0202","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1093\/nar\/gkm663","article-title":"Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells","volume":"35","author":"Vickers","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0203","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/nar\/29.6.1293","article-title":"Fully modified 2\u2032 MOE oligonucleotides redirect polyadenylation","volume":"29","author":"Vickers","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"10.1016\/j.heares.2022.108523_bib0204","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/hmg\/ddx234","article-title":"Rescue of peripheral vestibular function in Usher syndrome mice using a splice-switching antisense oligonucleotide","volume":"26","author":"Vijayakumar","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0205","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0748233711425067","article-title":"A weight of evidence approach for the assessment of the ototoxic potential of industrial chemicals","volume":"28","author":"Vyskocil","year":"2012","journal-title":"Toxicol Ind Health"},{"issue":"64","key":"10.1016\/j.heares.2022.108523_bib0206","doi-asserted-by":"crossref","DOI":"10.3791\/3653-v","article-title":"Gene transfer to the developing mouse inner ear by in vivo electroporation","author":"Wang","year":"2012","journal-title":"J Vis Exp"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0207","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1093\/nar\/gkaa194","article-title":"Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heares.2022.108523_bib0208","series-title":"The Mammalian Auditory Pathway: Neuroanatomy","author":"Webster","year":"1992"},{"issue":"4","key":"10.1016\/j.heares.2022.108523_bib0209","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s13555-021-00561-5","article-title":"Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa","volume":"11","author":"Welponer","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5938","key":"10.1016\/j.heares.2022.108523_bib0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.1173110","article-title":"Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA","volume":"325","author":"Wheeler","year":"2009","journal-title":"Science"},{"issue":"10111","key":"10.1016\/j.heares.2022.108523_bib0211","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(17)31073-5","article-title":"Global hearing health care: new findings and perspectives","volume":"390","author":"Wilson","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.heares.2022.108523_bib0212","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2017.09.032","article-title":"DNA nanostructure-based drug delivery nanosystems in cancer therapy","volume":"533","author":"Wu","year":"2017","journal-title":"Int J Pharm"},{"issue":"17","key":"10.1016\/j.heares.2022.108523_bib0214","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"issue":"6218","key":"10.1016\/j.heares.2022.108523_bib0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.1254806","article-title":"RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease","volume":"347","author":"Xiong","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.heares.2022.108523_bib0216","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated delivery of antisense oligonucleotides targeting alpha-synuclein ameliorates the pathology in a mouse model of Parkinson's disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.heares.2022.108523_bib0217","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2016.00461","article-title":"Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data","volume":"7","author":"Yildirim","year":"2016","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0218","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ymthe.2018.12.014","article-title":"Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness","volume":"27","author":"Yoshimura","year":"2019","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.heares.2022.108523_bib0219","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/s41598-018-21233-z","article-title":"Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation","volume":"8","author":"Yoshimura","year":"2018","journal-title":"Sci Rep"},{"issue":"1-2","key":"10.1016\/j.heares.2022.108523_bib0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijpharm.2017.06.035","article-title":"siRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicity","volume":"528","author":"Youm","year":"2017","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0221","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2012.01.021","article-title":"Intratympanic injection of shRNA-expressing lentivirus causes gene silencing in the inner ear in chicken","volume":"510","author":"Yu","year":"2012","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.heares.2022.108523_bib0222","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ejhg.2016.182","article-title":"The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands","volume":"25","author":"Zazo Seco","year":"2017","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.heares.2022.108523_bib0223","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112089","article-title":"Antagomirs targeting miR-142-5p attenuate pilocarpine-induced status epilepticus in mice","volume":"393","author":"Zhang","year":"2020","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.heares.2022.108523_bib0224","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fnmol.2018.00221","article-title":"Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success","volume":"11","author":"Zhang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.heares.2022.108523_bib0225","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000449239","article-title":"Hearing Loss after Round Window Surgery in Mice Is due to Middle Ear Effusion","volume":"21","author":"Zhu","year":"2016","journal-title":"Audiol Neurootol"}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595522000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595522000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:06:50Z","timestamp":1759921610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595522000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":225,"alternative-id":["S0378595522000922"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2022.108523","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altering gene expression using antisense oligonucleotide therapy for hearing loss","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2022.108523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108523"}}